144 related articles for article (PubMed ID: 30043425)
1. Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas.
Menard K; Flesner BK; Glahn A; Boudreaux B; Bryan JN
Vet Comp Oncol; 2018 Dec; 16(4):590-595. PubMed ID: 30043425
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
Gillem J; Giuffrida M; Krick E
Vet Comp Oncol; 2017 Jun; 15(2):400-410. PubMed ID: 26463827
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of concurrent carboplatin chemotherapy and radiation therapy in dogs.
Hume KR; Johnson JL; Williams LE
J Vet Intern Med; 2009; 23(1):24-30. PubMed ID: 19175716
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin-induced myelosuppression as related to body weight in dogs.
Coffee C; Roush JK; Higginbotham ML
Vet Comp Oncol; 2020 Dec; 18(4):804-810. PubMed ID: 32452107
[TBL] [Abstract][Full Text] [Related]
5. Combined gemcitabine and carboplatin therapy for carcinomas in dogs.
Dominguez PA; Dervisis NG; Cadile CD; Sarbu L; Kitchell BE
J Vet Intern Med; 2009; 23(1):130-7. PubMed ID: 19175731
[TBL] [Abstract][Full Text] [Related]
6. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder.
Chun R; Knapp DW; Widmer WR; DeNicola DB; Glickman NW; Kuczek T; Degortari A; Han CM
J Vet Intern Med; 1997; 11(5):279-83. PubMed ID: 9348494
[TBL] [Abstract][Full Text] [Related]
7. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
[TBL] [Abstract][Full Text] [Related]
9. Canine intranasal tumours treated with alternating carboplatin and doxorubin in conjunction with oral piroxicam: 29 cases.
Woodruff MJ; Heading KL; Bennett P
Vet Comp Oncol; 2019 Mar; 17(1):42-48. PubMed ID: 30146732
[TBL] [Abstract][Full Text] [Related]
10. Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.
Wouda RM; Hocker SE; Higginbotham ML
Vet Comp Oncol; 2018 Mar; 16(1):E52-E60. PubMed ID: 28799187
[TBL] [Abstract][Full Text] [Related]
11. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical evaluation of carboplatin in tumor-bearing cats: a Veterinary Cooperative Oncology Group study.
Kisseberth WC; Vail DM; Yaissle J; Jeglum KA; Couto CG; Ward H; Khanna C; Obradovich JE
J Vet Intern Med; 2008; 22(1):83-8. PubMed ID: 18289293
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and efficacy of a novel doxorubicin and carboplatin chemotherapy protocol for the treatment of canine appendicular osteosarcoma following limb amputation.
Lane A; Black M; Wyatt K
Aust Vet J; 2012 Mar; 90(3):69-74. PubMed ID: 22339117
[TBL] [Abstract][Full Text] [Related]
14. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
[TBL] [Abstract][Full Text] [Related]
16. Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study.
Barrett LE; Gardner HL; Barber LG; Sadowski A; London CA
BMC Vet Res; 2019 Aug; 15(1):291. PubMed ID: 31409327
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog.
Bailey D; Erb H; Williams L; Ruslander D; Hauck M
J Vet Intern Med; 2003; 17(2):199-205. PubMed ID: 12683621
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients.
Chambers SK; Davis CA; Chambers JT; Schwartz PE; Lorber MI; Hschumacher RE
Clin Cancer Res; 1996 Oct; 2(10):1699-704. PubMed ID: 9816119
[TBL] [Abstract][Full Text] [Related]
19. Outcome and prognostic factors in medically treated canine prostatic carcinomas: A multi-institutional study.
Ravicini S; Baines SJ; Taylor A; Amores-Fuster I; Mason SL; Treggiari E
Vet Comp Oncol; 2018 Dec; 16(4):450-458. PubMed ID: 29806232
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
